Regencell Bioscience Holdings Ltd

RGC

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
RGC
CIK0001829667
SIC2833
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupMedicinal Chemicals

Contact

Address11/F FIRST COMMERCIAL BUILDING, 33-35 LEIGHTON ROAD, CAUSEWAY BAY, HONG KONG, K3, 999077
Website regencellbioscience.com
Phone852 2155 0823
CEOYat-Gai Au
Employees10

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$0.00
Pre-Tax Income$-4.36 million
Net Income$-8.67 million
Net Income to Common$-4.30 million
EPS$-0.33
View All
Balance Sheet
Cash$2.96 million
Assets$8.44 million
Liabilities$219,512.00
Common Equity$8.22 million
Liabilities & Equity$8.44 million
View All
Cash Flow Statement
Calculations
NOPAT$-3.32 million
EBITDA$-3.62 million
Price to EarningsN/A
Price to Book$1,013.25
ROE-85.76%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Why Regencell Bioscience Holdings Limited (RGC) is Surging in 2025

We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Regencell Bioscience Holdings Limited (NASDAQ:RGC) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making […]

Article Link

Why Regencell Bioscience Holdings Ltd. (RGC) Surged On Thursday?

We recently published a list of 10 Micro-, Small-Cap Firms Dominate Thursday’s Gains. In this article, we are going to take a look at where Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) stands against other micro-, small-cap firms that dominate Thursday’s gains. The stock market edged lower on Thursday, erasing gains from the previous trading day that […]

Article Link

Why Regencell Bioscience Holdings Limited (RGC) Soared Last Week?

We recently published a list of These 10 Stocks Posted Double-, Triple-Digit Gains Last Week. In this article, we are going to take a look at where Regencell Bioscience Holdings Limited (NASDAQ:RGC) stands against other stocks that posted double-, triple-digit gains last week. Micro- and small-cap companies dominated gains on the stock market last week, bucking […]

Article Link

Insider Spends US$6.2m Buying More Shares In Regencell Bioscience Holdings

Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) shareholders (or potential shareholders) will be happy to see that...

Article Link

Insiders of Regencell Bioscience Holdings Limited (NASDAQ:RGC) have had a great week after last week's US$111m gain and they haven't stopped buying

Key Insights Significant insider control over Regencell Bioscience Holdings implies vested interests in company growth...

Article Link